Evidence map›Paper›PMID 34138447›Full record

Trial reportJournal of clinical psychology in medical settings2021

Exploring Fear of Cancer Recurrence in a Sample of Heterogeneous Distressed Cancer Patients with and Without a Psychiatric Disorder.

Else M Bisseling, Félix R Compen, Melanie P J Schellekens, Belinda Thewes, Anne E M Speckens, Marije L van der Lee

Registry-linked trialOpen access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Journal of clinical psychology in medical settings, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02138513 (), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02138513 nacompletednot on this map

(Cost-) Effectiveness of Mindfulness Based Cognitive Therapy (MBCT) in Cancer Patients: a Superiority Trial of Online and Face-to-face Treatment Versus Treatment as Usual (TAU).

TypeinterventionalSponsorRadboud University Medical CenterRan2014 to 2017Enrolled245ConditionsDistress, Anxiety, DepressionArmsMindfulness Based Cognitive Therapy
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Interconnectivity of fear of progression and generalized anxiety - Network analysis among a sample of hematological cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Else M BisselingDepartment of Psychiatry, Radboud University Medical Centre, 6525, EX, Nijmegen, The Netherlands. else.bisseling@radboudumc.nl.ORCID 0000-0003-2457-2428
Félix R CompenDepartment of Psychiatry, Radboud University Medical Centre, 6525, EX, Nijmegen, The Netherlands.ORCID 0000-0002-9988-6694
Melanie P J SchellekensDepartment of Psychiatry, Radboud University Medical Centre, 6525, EX, Nijmegen, The Netherlands.ORCID 0000-0001-8397-7674
Belinda ThewesSchool of Psychology, University of Sydney, Sydney, NSW, 2006, Australia.ORCID 0000-0002-4092-6161
Anne E M SpeckensDepartment of Psychiatry, Radboud University Medical Centre, 6525, EX, Nijmegen, The Netherlands.ORCID 0000-0001-5266-1554
Marije L van der LeeCentre for Psycho-Oncology, Scientific Research Department, Helen Dowling Institute, 3723, MB, Bilthoven, The Netherlands.ORCID 0000-0002-1316-7008
Radboud University Nijmegen · NLThe University of Sydney · AUTilburg University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fear of Cancer Recurrence (FCR) is a concern among cancer patients. Recent insights suggest that FCR should be viewed as a distinct syndrome. However, few studies have explored its overlap with psychiatric morbidity. We examined this overlap in a sample of distressed cancer patients. Self-referred patients (n = 245) were assessed with the Structured Clinical Interview for DSM-IV-TR Axis-I disorders and the Fear of Cancer Recurrence Inventory-Short Form. Proportions of patients with and without a psychiatric disorder meeting validated cut-offs for screening and clinically relevant FCR were compared. The prevalence of psychiatric disorders was 36%. Clinically relevant FCR was found in 198 patients (81%). Patients with a current psychiatric disorder reported clinically relevant FCR more frequently (89%) compared to those with no disorder (77%). Of patients reporting clinically relevant FCR, the majority (61%) did not additionally meet the criteria for a psychiatric disorder. These findings suggest that there should be particular attention for patients with elevated levels of FCR, warranting FCR-specific treatment.Trial registry number Clinicaltrials.gov NCT02138513.

Indexed as

FearPhobic DisordersEmotionsHumansNeoplasm Recurrence, LocalPrevalenceCancerFear of cancer recurrenceOncologyPsychiatric disorderPsychological distress

Identifiers

PMID34138447
PMCPMC8458175
OpenAlexW3170683517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.